Lupus affects an estimated 3.41 million people worldwide, with a global prevalence of roughly 44 per 100,000 people. That makes it uncommon but far from rare, especially among certain groups where rates are significantly higher. In the United States, about 204,000 people are living with systemic lupus erythematosus (SLE), the most serious form of the disease.
Lupus by the Numbers
Globally, about 44 out of every 100,000 people have SLE. That number shifts dramatically by sex: approximately 79 per 100,000 women compared to just 9 per 100,000 men. Of the 3.41 million people living with lupus worldwide, roughly 3.04 million are women and 360,000 are men. The female-to-male ratio ranges from 4:1 to as high as 11:1 depending on the population studied.
In the U.S., the CDC estimates that about 184,000 women and 20,000 men have SLE. These numbers come from population-based surveillance projects, so they likely undercount people who haven’t yet been diagnosed or who have milder forms of the disease.
Who Gets Lupus Most Often
Lupus does not affect all racial and ethnic groups equally. Data from the California Lupus Surveillance Project found that Black Americans had the highest rates by a wide margin: a prevalence of 241 per 100,000 people, compared to 95 per 100,000 for Hispanic Americans, 91 per 100,000 for Asian and Pacific Islander Americans, and 55 per 100,000 for white Americans. That means Black Americans are roughly four times more likely to have lupus than white Americans.
The disparity extends to new diagnoses as well. The incidence rate for Black Americans was 15.5 per 100,000 person-years, more than five times the rate of 2.8 per 100,000 for white Americans. Hispanic and Asian/Pacific Islander populations fell in between, at around 4.1 to 4.2 per 100,000. These differences likely reflect a combination of genetic susceptibility, environmental exposures, and disparities in healthcare access that can delay diagnosis and worsen outcomes.
Age at Diagnosis
Most people develop lupus during their childbearing years. Women are typically diagnosed between their mid-20s and mid-30s. Men tend to be diagnosed a bit later, often two to eleven years older than women at the time of onset. Between 10 and 20 percent of all people who develop SLE are diagnosed during childhood or adolescence, and childhood-onset lupus tends to be more aggressive than the adult form.
Different Types of Lupus
SLE is the form most people mean when they say “lupus,” but it’s not the only type. Cutaneous lupus (CLE) affects only the skin and is actually more common overall. In one U.S. study, the prevalence of cutaneous lupus was 70 per 100,000 compared to about 31 per 100,000 for SLE. The gap was particularly striking in men, where cutaneous lupus was far more prevalent than systemic lupus (57 versus 1.6 per 100,000).
Other forms include drug-induced lupus, which resolves after the triggering medication is stopped, and neonatal lupus, a rare condition in newborns of mothers with certain antibodies. Neither is well-tracked in population studies, but both are considerably less common than SLE or CLE.
How Long Diagnosis Takes
One reason lupus can seem rarer than it is: it’s notoriously difficult to diagnose. The median time from first symptoms to an official SLE diagnosis is about two years, but the range is wide. Some people wait much longer, with the middle 50 percent of patients experiencing delays spanning up to about four and a half years. Lupus symptoms overlap with dozens of other conditions, including fibromyalgia, rheumatoid arthritis, and thyroid disease. Joint pain, fatigue, and skin rashes can come and go unpredictably, which makes it easy for both patients and doctors to attribute them to something else.
Kidney Involvement and Other Complications
Lupus can affect virtually any organ, but the kidneys are one of the most common and consequential targets. About 38 percent of people with SLE develop lupus nephritis, a form of kidney inflammation. Most of those cases (roughly 81 percent) are already present at the time of diagnosis, while the rest develop during follow-up. Kidney involvement is one of the strongest predictors of long-term outcomes and a major reason why lupus requires ongoing monitoring even when symptoms feel manageable.
Neuropsychiatric involvement, which can include cognitive difficulties, seizures, or psychosis, is another complication that independently raises the risk of poor outcomes.
Survival and Outlook
The prognosis for lupus has improved substantially over the past several decades. Current data show a 10-year survival rate of about 90 percent, a 15-year rate of 88 percent, and a 20-year rate of roughly 80 percent. The leading causes of death among people with lupus are infections and severe neurological disease rather than lupus itself in many cases. Factors that worsen the outlook include kidney involvement, neuropsychiatric complications, and being diagnosed at an older age.
Early diagnosis and consistent management of organ damage make the biggest difference in survival. Many people with lupus live full, active lives, particularly when the disease is caught before significant organ involvement develops.